BIOAVAILABILITY OF ORAL TRIMETREXATE IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME

被引：11

作者：

ROGERS, P

ALLEGRA, CJ

MURPHY, RF

DRAKE, JC

MASUR, H

POPLACK, DG

CHABNER, BA

PARRILLO, JE

LANE, HC

BALIS, FM

机构：

[1] NCI,PEDIAT BRANCH,BETHESDA,MD 20892

[2] NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20892

[3] NCI,CTR CLIN,DEPT CRIT CARE MED,BETHESDA,MD 20892

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1988年 / 32卷 / 03期

关键词：

D O I：

10.1128/AAC.32.3.324

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

收藏

页码：324 / 326

页数：3

相关论文

共 16 条

[1] TRIMETREXATE FOR THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
ALLEGRA, CJ
CHABNER, BA
TUAZON, CU
OGATAARAKAKI, D
BAIRD, B
DRAKE, JC
SIMMONS, JT
LACK, EE
SHELHAMER, JH
BALIS, F
WALKER, R
KOVACS, JA
LANE, HC
MASUR, H
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (16) : 978 - 985
[2] BALIS FM, 1987, CANCER RES, V47, P4973
[3] BALIS FM, 1983, CANCER RES, V43, P2342
[4] BALIS FM, 1986, CANCER RES, V46, P169
[5] 2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL]QUINAZOLINE (TMQ), A POTENT NON-CLASSICAL FOLATE ANTAGONIST INHIBITOR .1. EFFECT ON DIHYDROFOLATE-REDUCTASE AND GROWTH OF RODENT TUMORS INVITRO AND INVIVO
BERTINO, JR
SAWICKI, WL
MOROSON, BA
CASHMORE, AR
ELSLAGER, EF
[J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (12) : 1983 - 1987
[6] DIDDENS H, 1983, CANCER RES, V43, P5286
[7] Gibaldi M., 1982, PHARMACOKINETICS, P445
[8] HENDERSON ES, 1965, CANCER RES, V25, P1018
[9] CLINICAL-PHARMACOLOGY OF TRIMETREXATE
HO, DHW
COVINGTON, WP
LEGHA, SS
NEWMAN, RA
KRAKOFF, IH
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (03) : 351 - 356
[10] UPTAKE AND EFFICACY OF TRIMETREXATE (TMQ, 2,4-DIAMINO-5-METHYL-6-[(3,4,5-TRIMETHOXYANILINO)METHYL] QUINAZOLINE), A NON-CLASSICAL ANTIFOLATE IN METHOTREXATE-RESISTANT LEUKEMIA-CELLS INVITRO
KAMEN, BA
EIBL, B
CASHMORE, A
BERTINO, J
[J]. BIOCHEMICAL PHARMACOLOGY, 1984, 33 (10) : 1697 - 1699